Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07456683 · ClinicalTrials.gov registry record · NA

The Effect of Water With Anti-Inflammatory Capabilities on the Inflammatory Response to Heavy Resistance Exercise

A NA study of Systemic Inflammation and Hydration, sponsored by University of Arkansas, Fayetteville.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07456683: Completed NA study of Systemic Inflammation and Hydration, sponsored by University of Arkansas, Fayetteville.

NCT07456683 is a NA study of Systemic Inflammation and Hydration that has completed, run by University of Arkansas, Fayetteville. The registered enrollment target is 40 participants, below the 799-participant average among 6 other Systemic Inflammation trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07456683, a NA study of Systemic Inflammation and Hydration, has completed, sponsored by University of Arkansas, Fayetteville.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to assess the anti-inflammatory effects of berry-flavored water in response to an acute bout of exercise. This investigation is part of a larger collaborative project between the Exercise Science Research Center, the Center for Human Nutrition, and the University of Arkansas Sensory Science Center, which seeks to examine the potential of waters infused with naturally occurring bioactive anti-inflammatory volatile compounds to improve overall health. We expect that this water infused with natural bioactive berry volatile compounds will demonstrate preventive physiological benefits in relation to systemic inflammation, including a decreased level of baseline (resting) inflammation and attenuated post-exercise inflammation.

Primary Outcome

Innflammatory biomarkers

Interventions

  • OTHER We made a water with berry essence volatiles (cranberry, blackberry, and blueberry). This was consumed for 6 weeks.

Study Locations (1)

Arkansas

  • University of Arkansas Exercise Science Research Center - Fayetteville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-05-17
Est. Completion 2024-02-10
Phase NA

What the finished NCT07456683 record still lists

NCT07456683 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 799-participant average among 6 other Systemic Inflammation trials with a reported enrollment target (95% lower).

The record links to 3 conditions, with Systemic Inflammation appearing as the primary indexed condition, and to 1 intervention - of which We made a water with berry essence volatiles (cranberry, blackberry, and blueberry). This was consumed for 6 weeks. is the first listed.

NCT07456683 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT07456683 about?

NCT07456683 is a clinical study titled "The Effect of Water With Anti-Inflammatory Capabilities on the Inflammatory Response to Heavy Resistance Exercise". The purpose of this research is to assess the anti-inflammatory effects of berry-flavored water in response to an acute bout of exercise. This investigation is part of a larger collaborative project between the Exercise Science Research Center, the Center for Human Nutrition, and the University of A...

What is the current status of trial NCT07456683?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-05-17. Estimated completion is 2024-02-10.

What conditions does trial NCT07456683 study?

This clinical trial studies the following conditions: Systemic Inflammation, Hydration, Resting Metabolism.

What interventions are being tested in trial NCT07456683?

The interventions under investigation include: We made a water with berry essence volatiles (cranberry, blackberry, and blueberry). This was consumed for 6 weeks. (OTHER).

Who is sponsoring clinical trial NCT07456683?

This trial is sponsored by University of Arkansas, Fayetteville, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07456683 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Systemic Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07456683, the US trial registry maintained by the National Library of Medicine. NCT07456683 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.